Evofem Biosciences, Inc. (EVFM) stock
EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-10.00%)
Close on Oct 19, 2026Market cap $865.23KP/E –Yield –
Evofem Biosciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Evofem Biosciences's total debt was $362.00K at Jun 30, 2026. For fiscal 2025 it was $147.00K, up 8.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.00K | +8.9% |
| FY2024 | Dec 31, 2024 | $135.00K | -98.6% |
| FY2015 | Dec 31, 2015 | $9.96M | +2.3% |
| FY2014 | Dec 31, 2014 | $9.74M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $362.00K | +168.1% |
| Q4 FY2025 | Dec 31, 2025 | $147.00K | -45.1% |
| Q3 FY2025 | Sep 30, 2025 | $291.00K | -26.7% |
| Q2 FY2025 | Jun 30, 2025 | $383.00K | -90.4% |
| Q4 FY2024 | Dec 31, 2024 | $135.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $268.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $397.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $4.00M | – |
See a number that looks wrong?